Dauntless Takes Flight with New Business Model for Starting Biotechs
Xconomy
JULY 20, 2016
Then came COI Pharmaceuticals , the shared “community of innovation” for startup biotechs established by San Diego’s Avalon Ventures as part of its partnership with GlaxoSmithKline. It’s a little like what Avalon is doing. We outsource everything. We are taking capital as needed, not sooner.”.
40 
Let's personalize your content